Table 1.
Crohn’s Disease Patient Demographics
| UCLA_ID | HLA-Bw | HLA-C | Age | Gender | Race | Age of Diagnosis | Current Medication |
|---|---|---|---|---|---|---|---|
| CDKIR0804 | Bw6 | C1 | 63 | F | Caucasian | 19 | None |
| CDKIR0805-88 | Bw4, Bw6 | C1 | 55 | F | Caucasian | 18 | Methotrexate, Darifenacin, Ciprofloxacin |
| CDKIR0816 | Bw4, Bw6 | C1 | 50 | F | Caucasian | 26 | Acetaminophen |
| CDKIR0822 | Bw4, Bw6 | C1 | 60 | F | Caucasian | 28 | Adalimumab, Clonazepam Mesalamine, Pravastatin, Zolpidem, Alprazolam |
| CDKIR0831 | Bw6 | C1 | 60 | F | Caucasian | 49 | Glatiramer acetate, Atorvastatin, Bupropion, Escitalopram, Nitrofurantoin |
| CDKIR0919 | Bw6 | C1 | 49 | F | Caucasian | 12 | Mesalamine, Rifaximin, Hydrochlorothiazide, Alprazolam, Acetaminophen and hydrocodone |
| CDKIR0921 | Bw4 | C1 | 50 | F | Caucasian | 21 | Methadone, Fentanyl citrate, Nexium |
| CDKIR1130 | Bw6 | C1 | 40 | F | Caucasian | 25 | Escitalopram, lorazepam |
| CDKIR1207 | Bw4 | C1 | 44 | M | Caucasian | 30 | 6-Mercaptopurine, Methotrexate, Mesalamine |
| CDKIR012512-49 | Bw4, Bw6 | C1 | 55 | F | Caucasian | 33 | 6-Mercaptopurine, infliximab, citalopram |
| CDKIR0805-01 | Bw6 | C1, C2 | 48 | F | Caucasian | 26 | Colesevelam, diphenoxylate and atropine, Doxorubicin, Cyclophosphamide, Aprepitant, Ondansetron, Prochlorperazine |
| CDKIR0811 | Bw4, Bw6 | C1, C2 | 62 | M | Caucasian | 25 | Infliximab |
| CDKIR0902 | Bw4 | C1, C2 | 41 | F | Caucasian | 33 | Loestrin 4Fe, Infliximab, Propranolol, Zolpidem |
| CDKIR0914 | Bw4 | C1, C2 | 63 | F | Caucasian | 31 | Adalimumab, diphenoxylate and atropine, Colestipol, Simvastatin, Levothyroxine, Montelukast, Belladonna alkaloids and phenobarbital, Acetaminophen and hydrocodone, Escitalopram, Ibandronate, Fioricet |
| CDKIR021712 | Bw4, Bw6 | C1, C2 | 40 | M | Caucasian | 22 | Mesalamine, Infliximab |
| CDKIR022412 | Bw6 | C1, C2 | 47 | M | Caucasian | 7 | Lisinopril, Fluoxetine, Bupropion, Prednisone |
| CDKIR0805-04 | Bw4, Bw6 | C2 | 31 | M | Caucasian | 22 | 6-Mercaptopurine |
| CDKIR0809 | Bw4, Bw6 | C2 | 46 | M | Caucasian | 30 | Adalimumab, Lisdexamfetamine, Duloxetine, Cyanocobalamin (b12) |
| CDKIR1014 | Bw4 | C2 | 42 | M | Caucasian | 17 | 6-Mercaptopurine, Dicyclomine, Zolpidem, Alprazolam, Amlodipine besylate, Metoprolol, Prednisone, Dexlansoprazole, Ondansetron, Adalimumab |
| CDKIR012512-50 | Bw4, Bw6 | C2 | 43 | M | Caucasian | 33 | Acetaminophen, Cyclosporine, Adalimumab, Losartan Potassium, Cefuroxime |